The optimal solution thanks to IMS
Musashi Europe GmbH, a leading provider of precision components for the automotive industry, faced the challenge of applying for the research grant. In a conversation with Walter Bläs, Director of Engineering at Musashi, we learn how innoscripta supported the company with their expertise and innovative IMS software to successfully manage this complex endeavor.
Successfully navigating the application process with innoscripta
In February 2021, Musashi Europe became aware of the possibility of the research grant.
Walter Bläs says: “We had contact with various providers, but innoscripta stood out. Applying for the research grant is not a simple process, and Musashi had little prior experience in this area.”
innoscripta helped Musashi with the application for the research grant through the Certification Body for Research Grants (BSFZ) and with preparing the documentation for the second application step at the tax office. The IMS platform made cost calculations and documentation significantly easier. This gave Musashi the confidence to know they had an experienced partner at their side.
Walter Bläs notes: “We can prepare the documentation for the research grant in Excel as well, but all necessary data is stored in the IMS and documented in a tamper-proof way.”
innoscripta impressed Musashi not only with their many years of experience, but also with their innovative IMS platform.
“I really liked innoscripta’s software. The user interface is clearly structured and provides an excellent basis for documentation,” says Walter Bläs.
Looking to the future together
Musashi Europe continues to work with innoscripta to save time and focus on their core activities.
“If something goes wrong or questions arise during the application process, we know there’s always a contact person available at innoscripta. This gives us more time to do what we love: developing groundbreaking technologies,” emphasizes Walter Bläs.
He especially appreciates the personal interaction and the family-like atmosphere at innoscripta. Together with innoscripta, Musashi looks optimistically to the future and is excited to continue the successful collaboration.